Transcript
Early results from a coronavirus vaccine trial in the US show positive results.
That’s according to a press release issued Monday by biotech company “Moderna” based in Massachusetts.
Moderna is partnering with the National Institutes of Health to develop a vaccine.
Participants who received a COVID-19 vaccine by Moderna have developed antibodies against the virus.
The trial was very small and the results haven’t been peer reviewed or published in a medical journal.
But Moderna’s chief medical officer says that if the future studies go well the vaccine could be available to the public as early as January.
Posted – 5.19.20